Financials
- Market Capitalization 259.99 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.36
Relación precio/flujo de caja
2.41
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3338 | EYPT EyePoint, Inc. - Common Stock | 3.07 USD | -7.53% | -1.29% | -28.10% | -74.42% | 264.67 M USD | ||
| 3351 | NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.05 USD | -5.53% | +22.75% | +127.78% | +107.07% | 260.87 M USD | ||
| 3355 | ABEO Abeona Therapeutics Inc. - Common Stock | 4.52 USD | -7.76% | -8.69% | -16.61% | -15.51% | 258.47 M USD | ||
| 3357 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 2.60 USD | -7.80% | -5.11% | -27.78% | -12.46% | 257.78 M USD |